Trial Profile
A Prospective, Double-blind, Randomized Study to Compare Efficacy of Two Etanercept Regimens (REUMATOCEPT Versus ENBREL) for Treatment of Rheumatoid Arthritis
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 25 Feb 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors EMS Sigma Farma
- 23 Feb 2021 Status changed from suspended to withdrawn prior to enrolment due to sponsor decision.
- 01 Mar 2013 Planned End Date changed from 1 Jun 2012 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 01 Mar 2013 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.